Craig Wong-Pan
Stock Analyst at RBC Capital
(0.94)
# 3,869
Out of 4,600 analysts
314
Total ratings
46.8%
Success rate
-1.5%
Average return
Main Sectors:
Stocks Rated by Craig Wong-Pan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Hold | $18.00 | $14.66 | +22.82% | 7 | Jul 21, 2026 | |
| TPR Tapestry | Downgraded: Hold | $81 | $155.97 | -47.78% | 1 | Jul 16, 2026 | |
| RMD ResMed | Downgraded: Hold | $276 → $234 | $223.14 | +4.87% | 36 | Jul 16, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Buy | $41.00 → $36.00 | $33.95 | +6.04% | 8 | Jul 16, 2026 | |
| ASX: COH Cochlear Limited | Downgraded: Hold | $125.00 → $117.00 | $122.03 | -4.12% | 21 | Jul 16, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $107.00 → $108.00 | $130.07 | -16.97% | 33 | Jul 16, 2026 | |
| ASX: NAN Nanosonics Limited | Maintained: Hold | $3.75 → $3.50 | $3.42 | +2.49% | 18 | Jul 16, 2026 | |
| ASX: HLS Healius Limited | Maintained: Sell | $0.35 | $0.41 | -14.63% | 30 | Jul 16, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $45.00 → $49.00 | $43.89 | +11.66% | 22 | Jul 16, 2026 | |
| ASX: REG Regis Healthcare Limited | Maintained: Buy | $7.50 | $6.31 | +18.86% | 28 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.13 → $0.12 | $0.10 | +26.32% | 23 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23.00 → $22.00 | $21.89 | +0.53% | 25 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.05 → $2.85 | $2.22 | +28.38% | 22 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.40 → $2.35 | $2.43 | -3.09% | 20 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.75 → $0.72 | $0.70 | +3.60% | 13 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $37.16 → $34.00 | $42.29 | -19.60% | 4 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16.04 | $26.74 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31.60 | $15.03 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6.57 | $22.68 | n/a | 1 | May 22, 2019 |
Telix Pharmaceuticals Limited
Jul 21, 2026
Maintained: Hold
Price Target: $18.00
Current: $14.66
Upside: +22.82%
Tapestry
Jul 16, 2026
Downgraded: Hold
Price Target: $81
Current: $155.97
Upside: -47.78%
ResMed
Jul 16, 2026
Downgraded: Hold
Price Target: $276 → $234
Current: $223.14
Upside: +4.87%
Ansell Limited
Jul 16, 2026
Maintained: Buy
Price Target: $41.00 → $36.00
Current: $33.95
Upside: +6.04%
Cochlear Limited
Jul 16, 2026
Downgraded: Hold
Price Target: $125.00 → $117.00
Current: $122.03
Upside: -4.12%
CSL Limited
Jul 16, 2026
Maintained: Hold
Price Target: $107.00 → $108.00
Current: $130.07
Upside: -16.97%
Nanosonics Limited
Jul 16, 2026
Maintained: Hold
Price Target: $3.75 → $3.50
Current: $3.42
Upside: +2.49%
Healius Limited
Jul 16, 2026
Maintained: Sell
Price Target: $0.35
Current: $0.41
Upside: -14.63%
Ramsay Health Care Limited
Jul 16, 2026
Maintained: Hold
Price Target: $45.00 → $49.00
Current: $43.89
Upside: +11.66%
Regis Healthcare Limited
Jul 16, 2026
Maintained: Buy
Price Target: $7.50
Current: $6.31
Upside: +18.86%
Jul 16, 2026
Maintained: Hold
Price Target: $0.13 → $0.12
Current: $0.10
Upside: +26.32%
Jul 16, 2026
Maintained: Hold
Price Target: $23.00 → $22.00
Current: $21.89
Upside: +0.53%
Jul 16, 2026
Maintained: Buy
Price Target: $3.05 → $2.85
Current: $2.22
Upside: +28.38%
Jul 16, 2026
Maintained: Hold
Price Target: $2.40 → $2.35
Current: $2.43
Upside: -3.09%
Jun 11, 2026
Maintained: Hold
Price Target: $0.75 → $0.72
Current: $0.70
Upside: +3.60%
May 26, 2026
Upgraded: Hold
Price Target: $37.16 → $34.00
Current: $42.29
Upside: -19.60%
Oct 6, 2020
Maintained: Sell
Price Target: $16.04
Current: $26.74
Upside: n/a
Oct 6, 2020
Maintained: Buy
Price Target: $31.60
Current: $15.03
Upside: n/a
May 22, 2019
Downgraded: Sell
Price Target: $6.57
Current: $22.68
Upside: n/a